“So far this year, from my perspective, it’s been a little bit of a subdued season because of the cold, wet weather,” he said. Typically, tree pollen makes the rounds from mid February to late May or early June. Grass season, which is still to come, is usually the worst of all..
Merchants Hospitality: Founded 31 years ago, Merchants Hospitality and its Principals have owned, operated, and developed some of the most luxurious destinations in the country and Caribbean. Properties have included Hotels, Residential Condominiums, Office Buildings and Restaurants including 485 Fifth Avenue, currently home to the Hyatt Andaz, the Beekman Hotel at UN Plaza, 260 Park Avenue South Luxury Condominium, Aruba Starwood Hotel, Resort Time Share, NYC’s famous Pier 15 at South Street Seaport, and 350 Madison Avenue to name a few. Merchants also owns 18 premier restaurants in NYC including Philippe Chow on 60th and Madison, which is one of NYC’s most profitable restaurants per NYC F 2016.
The FDA has approved GW Pharmaceuticals drug, Epidiolex, for the treatment of severe seizures in children with epilepsy. This is the first pharmaceutical grade version of cannabidiol approved as a treatment for a serious and life threatening disease.The approval dovetails with a concerted effort by university and pharmaceutical researchers to test CBD effectiveness against a variety of diseases and disorders. The combination of the FDA approval of Epidiolex, with the ongoing scientific and clinical research on CBD, bodes well for other pharmacological targets for the cannabis derived compound.With analysts estimating that Epidiolex could be a US$1 billion drug for GW Pharmaceuticals, the market is beginning to give this sector of pharmaceutical research a closer look.What investors are finding is four publicly traded companies, including GW Pharmaceuticals, that offer exposure to pharma grade CBD products.
“We are pleased that Carl Romstadt is heading up our sales force in northern California,” said Ed Eberhard, president and chief operating officer of DentiCare. “Carl is a seasoned sales executive who knows the marketplace well. We look forward to his leadership in this market as our companies continue to grow and increase their market share.”.